More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|4|1|288-288

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.4, Iss.1, 2006-01, pp. : 288-288

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation

By Gielen-Wijffels S.   Mook W.   Geest S.   Ramsay G.  

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1232-1234

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation – A Retrospective Analysis

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 135-139

Karger

Access to resources Recommend Favorite

Successful Treatment of Hepatic Sinusoidal Obstructive Syndrome after Hematopoietic Stem Cell Transplantation in a Child Using Recombinant Thrombomodulin

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-11 ,pp. : 62-64

Karger

Access to resources Recommend Favorite

Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 162-163

Karger

Access to resources Recommend Favorite